ANCHOR is an observational and real-world study that aims to advance the understanding of cancer and improve the delivery of cancer care. Adopting a population health research approach, ANCHOR uses comprehensive patient data to understand the impact of the cancer journey on the patient and their experience. The study will be conducted for a period of 30 years, from 2010-2040. For more information, visit www.nccs.com.sg/research-innovation/research-programmes/anchor, or reach out to the ANCHOR team by calling (+65) 63065522.
The National Cancer Centre Singapore (NCCS) is a leading national and regional tertiary cancer centre with specialists who are experts in treating cancer. In addition to offering holistic and multidisciplinary oncology care, our clinicians and scientists collaborate with local and international partners to conduct robust, cutting-edge clinical and translational research. To achieve its vision of being a global leading cancer centre, NCCS offers world-class care and shares its depth of experience and expertise by training local and overseas medical professionals.
To meet growing healthcare needs, the new NCCS building opened in 2023 with increased capacity and expanded facilities dedicated to cancer care, rehabilitation, research and education. To give patients the best treatment outcomes, advanced and innovative treatment such as proton therapy is offered at the new Goh Cheng Liang Proton Therapy Centre at NCCS.
For more information, please visit: www.nccs.com.sg.